Risk Factors for Development of Acute Leukaemias and Myelodysplastic Syndromes in Nairobi

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Hematology and hematologic malignancies Pathology

Investigator from Ghent University

Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation

Leukaemia

David A Scheinberg

Mechanisms of action of a TCR-like antibody to WT1

Leukaemia

Marina Y Konopleva

Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy

Leukaemia

Hematology and hematologic malignancies Pathology

Ross L Levine

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

Leukaemia

James L M Ferrara

Cellular and Molecular Studies of Bone Marrow Transplant

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies

John Dick

Identify and understand the differences between normal HSCs and LSCs (CANADA RESEARCH CHAIRHOLDER)

Leukaemia

Linda Ya-Ting Chang

Role of innate immune signaling in myelodysplastic syndromes

Leukaemia

Tracy G Anthony

Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.

Leukaemia

Pediatric oncology or childhood cancer